Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
17.91
-1.36 (-7.06%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $1.20 billion as of April 25, 2025. Its market cap has increased by 194.45% in one year.
Market Cap
1.20B
Enterprise Value
1.10B
1-Year Change
194.45%
Ranking
Category
Stock Price
$17.91
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $1.20B, an increase of 2,199.38%. That is a compound annual growth rate of 41.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 1.20B | 12.50% |
| Dec 31, 2024 | 1.07B | 59.11% |
| Dec 29, 2023 | 673.10M | 552.86% |
| Dec 30, 2022 | 103.10M | -76.50% |
| Dec 31, 2021 | 438.80M | -27.42% |
| Dec 31, 2020 | 604.60M | 116.86% |
| Dec 31, 2019 | 278.80M | 43.19% |
| Dec 31, 2018 | 194.70M | -49.52% |
| Dec 29, 2017 | 385.70M | 345.90% |
| Dec 30, 2016 | 86.50M | 65.08% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.39B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |